Literature DB >> 34385710

Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause.

Junhua Zhou1,2, Elena A B Azizan3,4, Claudia P Cabrera2,5, Fabio L Fernandes-Rosa6, Sheerazed Boulkroun6, Giulia Argentesi1,2, Emily Cottrell7, Laurence Amar6,8, Xilin Wu1,2, Sam O'Toole1,2, Emily Goodchild1,2, Alison Marker9, Russell Senanayake10, Sumedha Garg1,2,10, Tobias Åkerström11, Samuel Backman11, Suzanne Jordan12, Satyamaanasa Polubothu13, Daniel M Berney14, Anna Gluck15, Kate E Lines15, Rajesh V Thakker15, Antoinette Tuthill16, Caroline Joyce17, Juan Pablo Kaski18, Fiona E Karet Frankl19, Lou A Metherell7, Ada E D Teo20, Mark Gurnell10, Laila Parvanta21, William M Drake22, Eva Wozniak23, David Klinzing24, Jyn Ling Kuan24, Zenia Tiang24,25, Celso E Gomez Sanchez26, Per Hellman11, Roger S Y Foo24, Charles A Mein23, Veronica A Kinsler12, Peyman Björklund11, Helen L Storr7, Maria-Christina Zennaro27,28, Morris J Brown29,30.   

Abstract

Most aldosterone-producing adenomas (APAs) have gain-of-function somatic mutations of ion channels or transporters. However, their frequency in aldosterone-producing cell clusters of normal adrenal gland suggests a requirement for codriver mutations in APAs. Here we identified gain-of-function mutations in both CTNNB1 and GNA11 by whole-exome sequencing of 3/41 APAs. Further sequencing of known CTNNB1-mutant APAs led to a total of 16 of 27 (59%) with a somatic p.Gln209His, p.Gln209Pro or p.Gln209Leu mutation of GNA11 or GNAQ. Solitary GNA11 mutations were found in hyperplastic zona glomerulosa adjacent to double-mutant APAs. Nine of ten patients in our UK/Irish cohort presented in puberty, pregnancy or menopause. Among multiple transcripts upregulated more than tenfold in double-mutant APAs was LHCGR, the receptor for luteinizing or pregnancy hormone (human chorionic gonadotropin). Transfections of adrenocortical cells demonstrated additive effects of GNA11 and CTNNB1 mutations on aldosterone secretion and expression of genes upregulated in double-mutant APAs. In adrenal cortex, GNA11/Q mutations appear clinically silent without a codriver mutation of CTNNB1.
© 2021. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34385710      PMCID: PMC9082578          DOI: 10.1038/s41588-021-00906-y

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   41.307


  76 in total

1.  Mutated alpha subunit of the Gq protein induces malignant transformation in NIH 3T3 cells.

Authors:  G Kalinec; A J Nazarali; S Hermouet; N Xu; J S Gutkind
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

2.  Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ.

Authors:  Matthew D Shirley; Hao Tang; Carol J Gallione; Joseph D Baugher; Laurence P Frelin; Bernard Cohen; Paula E North; Douglas A Marchuk; Anne M Comi; Jonathan Pevsner
Journal:  N Engl J Med       Date:  2013-05-08       Impact factor: 91.245

3.  Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks.

Authors:  Kazutaka Nanba; Kei Omata; Celso E Gomez-Sanchez; Constantine A Stratakis; Andrew P Demidowich; Mari Suzuki; Lester D R Thompson; Debbie L Cohen; James M Luther; Lan Gellert; Anand Vaidya; Justine A Barletta; Tobias Else; Thomas J Giordano; Scott A Tomlins; William E Rainey
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

4.  Pregnancy, Primary Aldosteronism, and Somatic CTNNB1 Mutations.

Authors:  Timothy D Murtha; Tobias Carling; Ute I Scholl
Journal:  N Engl J Med       Date:  2016-04-14       Impact factor: 91.245

5.  Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.

Authors:  Frédérique Tissier; Catherine Cavard; Lionel Groussin; Karine Perlemoine; Gwladys Fumey; Anne-Marie Hagneré; Fernande René-Corail; Eric Jullian; Christine Gicquel; Xavier Bertagna; Marie-Cécile Vacher-Lavenu; Christine Perret; Jérôme Bertherat
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

6.  Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas.

Authors:  Timothy J Burton; Isla S Mackenzie; Kottekkattu Balan; Brendan Koo; Nick Bird; Dmitri V Soloviev; Elena A B Azizan; Franklin Aigbirhio; Mark Gurnell; Morris J Brown
Journal:  J Clin Endocrinol Metab       Date:  2011-11-23       Impact factor: 5.958

7.  Development of monoclonal antibodies against human CYP11B1 and CYP11B2.

Authors:  Celso E Gomez-Sanchez; Xin Qi; Carolina Velarde-Miranda; Maria W Plonczynski; C Richard Parker; William Rainey; Fumitoshi Satoh; Takashi Maekawa; Yasuhiro Nakamura; Hironobu Sasano; Elise P Gomez-Sanchez
Journal:  Mol Cell Endocrinol       Date:  2013-12-08       Impact factor: 4.102

8.  Frequent mutations of beta-catenin gene in sporadic secreting adrenocortical adenomas.

Authors:  Mimi Tadjine; Antoine Lampron; Lydia Ouadi; Isabelle Bourdeau
Journal:  Clin Endocrinol (Oxf)       Date:  2007-09-14       Impact factor: 3.478

9.  Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands.

Authors:  Koshiro Nishimoto; Scott A Tomlins; Rork Kuick; Andi K Cani; Thomas J Giordano; Daniel H Hovelson; Chia-Jen Liu; Aalok R Sanjanwala; Michael A Edwards; Celso E Gomez-Sanchez; Kazutaka Nanba; William E Rainey
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-03       Impact factor: 11.205

10.  Concomitant driver mutations in advanced EGFR-mutated non-small-cell lung cancer and their impact on erlotinib treatment.

Authors:  Jan Nyrop Jakobsen; Eric Santoni-Rugiu; Morten Grauslund; Linea Melchior; Jens Benn Sørensen
Journal:  Oncotarget       Date:  2018-05-25
View more
  7 in total

1.  Targeted Mutational Analysis of Cortisol-Producing Adenomas.

Authors:  Juilee Rege; Jessie Hoxie; Chia-Jen Liu; Morgan N Cash; James M Luther; Lan Gellert; Adina F Turcu; Tobias Else; Thomas J Giordano; Aaron M Udager; William E Rainey; Kazutaka Nanba
Journal:  J Clin Endocrinol Metab       Date:  2022-01-18       Impact factor: 6.134

2.  Maternally Inherited Essential Hypertension: Adding Further Complexity to an Already Complex Condition.

Authors:  Christian Delles
Journal:  Am J Hypertens       Date:  2022-01-05       Impact factor: 3.080

Review 3.  Aldosterone-Regulated Sodium Transport and Blood Pressure.

Authors:  Akaki Tsilosani; Chao Gao; Wenzheng Zhang
Journal:  Front Physiol       Date:  2022-02-07       Impact factor: 4.566

Review 4.  Genetics of Primary Aldosteronism.

Authors:  Ute I Scholl
Journal:  Hypertension       Date:  2022-02-10       Impact factor: 10.190

Review 5.  A brief overview about the adipokine: Isthmin-1.

Authors:  Min Hu; Xin Zhang; Can Hu; Teng Teng; Qi-Zhu Tang
Journal:  Front Cardiovasc Med       Date:  2022-07-26

Review 6.  Primary aldosteronism: Pathophysiological mechanisms of cell death and proliferation.

Authors:  Martina Tetti; Siyuan Gong; Franco Veglio; Martin Reincke; Tracy Ann Williams
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-08       Impact factor: 6.055

7.  Identification of risk loci for primary aldosteronism in genome-wide association studies.

Authors:  Edith Le Floch; Teresa Cosentino; Casper K Larsen; Felix Beuschlein; Martin Reincke; Laurence Amar; Gian-Paolo Rossi; Kelly De Sousa; Stéphanie Baron; Sophie Chantalat; Benjamin Saintpierre; Livia Lenzini; Arthur Frouin; Isabelle Giscos-Douriez; Matthis Ferey; Alaa B Abdellatif; Tchao Meatchi; Jean-Philippe Empana; Xavier Jouven; Christian Gieger; Melanie Waldenberger; Annette Peters; Daniele Cusi; Erika Salvi; Pierre Meneton; Mathilde Touvier; Mélanie Deschasaux; Nathalie Druesne-Pecollo; Sheerazed Boulkroun; Fabio L Fernandes-Rosa; Jean-François Deleuze; Xavier Jeunemaitre; Maria-Christina Zennaro
Journal:  Nat Commun       Date:  2022-09-03       Impact factor: 17.694

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.